证券代码：600800 证券简称：渤海化学 公告编号：临 2025-045 天津渤海化学股份有限公司 关于新增 2025 年度预计日常性关联交易的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗 漏，并对其内容的真实性、准确性和完整性承担法律责任。 本关联交易事项经天津渤海化学股份有限公司（以下简称"公 司"）第十届董事会第十八次会议审议通过，尚需提交公司股东大会 审议，关联股东将在股东大会上对该议案回避表决。 本次新增 2025 年度预计日常性关联交易系公司日常经营活动 实际需要，交易遵循公允、合理的原则，符合公司及全体股东的利益， 不会损害公司股东，特别是中小股东的利益，对公司本期及未来财务 状况、经营成果无负面影响，亦不影响公司的独立性。 一、日常关联交易基本情况 为满足公司子公司天津渤海石化有限公司（以下简称"渤海石化"） 业务正常发展以及应对关税问题，渤海石化计划新增采购、销售业务， 交易方为天津渤海化工集团有限责任公司（以下简称"渤化集团"） 控制的子公司。本次新增 2025 年度预计日常关联交易金额为人民币 130,000.00 万元，调整后 2025 年度日常 ...

天津渤海化学股份有限公司 证券代码：600800 证券简称：渤海化学 公告编号：2025-047 关于召开2025年第三次临时股东大会的通知 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 一、 召开会议的基本情况 (四)现场会议召开的日期、时间和地点 召开的日期时间：2025 年 9 月 29 日 14 点 00 分 召开地点：公司会议室 (六)融资融券、转融通、约定购回业务账户和沪股通投资者的投票程序 涉及融资融券、转融通业务、约定购回业务相关账户以及沪股通投资者 的投票，应按照《上海证券交易所上市公司自律监管指引第 1 号 — 规范运 作》等有关规定执行。 (七)涉及公开征集股东投票权 股东大会召开日期：2025年9月29日 本次股东大会采用的网络投票系统：上海证券交易所股东大会网络投票 系统 (一)股东大会类型和届次 2025年第三次临时股东大会 (二)股东大会召集人：董事会 (三)投票方式：本次股东大会所采用的表决方式是现场投票和网络投票相结合的 方式 (五)网络投票的系统、起止日期和投票时间。 网络 ...

证券代码：600800 证券简称：渤海化学 编号：临 2025-046 天津渤海化学股份有限公司 关于第十届监事会第十六次会议决议的公告 详见公司同日刊登于上海证券交易所和《上海证券报》《中国证 券报》的《天津渤海化学股份有限公司关于新增 2025 年度预计日常 性关联交易的议案的公告》（公告号：临 2025-045）。 一、关于公开挂牌转让解放南路 325 号房产及附属物的议案 表决结果：同意 5 票；反对 0 票；弃权 0 票。 详见公司同日刊登于上海证券交易所和《上海证券报》《中国证 券报》的《天津渤海化学股份有限公司关于公开挂牌转让解放南路 325 号房产及附属物的公告》（公告号：临 2025-044）。 二、关于新增 2025 年度预计日常性关联交易的议案 表决结果：同意 2 票；反对 0 票；弃权 0 票；回避 3 票。 关联监事戴宜丰、李胜男、刘伟回避表决。 无法形成决议，直接将议案二提交股东大会审议。 本公司监事会及全体监事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗 漏，并对其内容的真实性、准确性和完整性承担法律责任。 天津渤海化学股份有限公司第十届监事会第十六次会议于 2025 ...

本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗 漏，并对其内容的真实性、准确性和完整性承担法律责任。 天津渤海化学股份有限公司（以下简称"公司"）第十届董事会 第十八次会议于 2025 年 9 月 5 日以电话及电子邮件方式通知各位董 事，会议于 2025 年 9 月 12 日 9:00 在公司召开，会议应到董事 9 人， 实到董事 9 人，公司高管人员及部分监事会成员列席了本次会议。会 议由董事长郭子敬先生主持，符合《公司法》《公司章程》的有关规 定，会议审议通过了如下议案： 一、关于公开挂牌转让解放南路 325 号房产及附属物的议案 本议案已经公司十届十五次董事会审计委员会事前认可并同意 提交董事会。 表决结果：同意 9 票；反对 0 票；弃权 0 票。 证券代码：600800 证券简称：渤海化学 编号：临 2025-043 天津渤海化学股份有限公司 关于第十届董事会第十八次会议决议的公告 详见公司同日刊登于上海证券交易所和《上海证券报》《中国证 券报》的《天津渤海化学股份有限公司关于新增 2025 年度预计日常 性关联交易的公告》（公告号：临 2025-045）。 三、关于 ...

Core Viewpoint - Bohai Chemical (600800.SH) plans to publicly transfer its property located at 325 Jiefang South Road, Hexi District, Tianjin, with a minimum listing price of RMB 137 million, with the final transaction amount to be determined by the actual sale price [1] Summary by Relevant Categories Company Actions - The company is initiating a public listing for the transfer of its property, indicating a strategic move to capitalize on its real estate assets [1] - The pricing strategy is based on a comprehensive assessment of the industrial property’s valuation, future commercial value, potential for building renovation appreciation, and stable long-term rental income [1] Financial Aspects - The minimum listing price for the property is set at RMB 137 million, reflecting a premium pricing approach within a reasonable range [1] - The actual transfer price will be determined based on the final listing transaction price, suggesting potential for variability in the final financial outcome [1]

Core Viewpoint - Bohai Chemical (600800.SH) plans to publicly transfer its idle asset located at 325 Jiefang South Road, Hexi District, Tianjin, for no less than 137 million yuan to enhance operational efficiency and align with its strategic development needs [1] Group 1: Asset Transfer Details - The asset's book value as of March 31, 2025, is 27.2345 million yuan, while its assessed value is 66.4544 million yuan, indicating an appreciation rate of 144.01% [1] - The anticipated profit from this asset disposal is projected to be 90 million yuan if the asset is sold at the listed price [1] Group 2: Strategic Implications - The transaction aims to focus on the company's core business development, reduce operational costs, and improve asset utilization efficiency [1]

Core Viewpoint - Bohai Chemical (600800.SH) plans to publicly transfer its property located at 325 Jiefang South Road, Hexi District, Tianjin, for no less than 137 million yuan to enhance operational efficiency and focus on core business development [1] Group 1: Asset Transfer Details - The property has a book value of 27.2345 million yuan and an assessed value of 66.4544 million yuan, indicating an appreciation rate of 144.01% [1] - The anticipated profit from this asset disposal is projected to be 90 million yuan if the property is sold at the listed price [1] Group 2: Strategic Intent - The transaction aligns with the company's strategic development needs by revitalizing idle assets and reducing operational costs [1] - The company aims to improve asset utilization efficiency through this transfer [1]

证券代码：600800 证券简称：渤海化学 编号：临 2025-042 天津渤海化学股份有限公司 一、会议主题 天津渤海化学股份有限公司（以下简称"公司"）为进一步加强 与投资者的沟通交流，公司定于 2025 年 9 月 11 日（周四）下午 15:00-17:00 期间参加由天津证监局主办、天津上市公司协会与深圳 市全景网络有限公司共同协办的"2025 年投资者网上集体接待日暨 半年报业绩说明会"活动。本次活动将采用网络远程的方式举行，投 资者可登录"全景路演"网站（http://rs.p5w.net）；或关注微信公 众号（名称：全景财经）；或下载全景路演 APP，参与本次互动交流。 二、召开时间和方式 会议召开时间：2025 年 9 月 11 日（周四）下午 15:00-17:00 会议召开地点：全景路演（http://rs.p5w.net） 会议召开方式：网络互动交流 三、出席会议人员 关于参加"天津辖区上市公司 2025 年投资者网上集体接待 日暨半年报业绩说明会"的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗 漏，并对其内容的真实性、准确性和完整性承担法律责任。 ...

Core Viewpoint - Bohai Chemical's stock price has decreased by 8.97% over the past week, with a current market capitalization of 4.16 yuan and a total market value of 4.618 billion yuan [1] Group 1: Stockholder Changes - As of June 30, 2025, the number of shareholders for Bohai Chemical is 51,500, a decrease of 5,464 shareholders or 9.59% compared to March 31, 2025 [2] Group 2: Performance Disclosure Highlights - Bohai Chemical's mid-year report for 2025 shows a main revenue of 1.961 billion yuan, a year-on-year decrease of 21.73% - The net profit attributable to shareholders is -359 million yuan, down 13.68% year-on-year - The second quarter alone reported a main revenue of 1.122 billion yuan, a decline of 6.46% year-on-year, with a net profit of -190 million yuan, down 37.38% year-on-year - The company's debt ratio stands at 65.01%, with a gross profit margin of -9.24% and financial expenses of 25.37 million yuan [3][6] Group 3: Company Announcements Summary - Bohai Chemical will not distribute profits or increase capital reserves for the first half of 2025 - The board has approved the half-year report and related financial assessments - Tianjin Bohai Group Financial Co., Ltd. reported total assets of 7.156 billion yuan and total liabilities of 5.284 billion yuan as of June 30, 2025 - The company raised a total of approximately 706 million yuan through a non-public offering, with a remaining balance of about 257 million yuan for new material projects due to previous project overcapacity [4][6]

Core Insights - Bohai Chemical (600800) reported a significant decline in financial performance for the first half of 2025, with total revenue of 1.961 billion yuan, down 21.73% year-on-year, and a net loss attributable to shareholders of 359 million yuan, a decrease of 13.68% compared to the previous year [1] Financial Performance Summary - Total revenue for the second quarter was 1.122 billion yuan, reflecting a year-on-year decrease of 6.46% [1] - The company's gross margin was -9.24%, down 12.23% year-on-year, while the net margin fell to -18.29%, a decline of 45.25% [1] - Total expenses (selling, administrative, and financial) amounted to 89.03 million yuan, representing 4.54% of revenue, an increase of 43.46% year-on-year [1] - Earnings per share decreased to -0.32 yuan, down 14.29% year-on-year, and operating cash flow per share was -0.37 yuan, a drastic decline of 447.27% [1] Balance Sheet Analysis - Cash and cash equivalents decreased by 60.64% to 509 million yuan due to increased funding needs for production recovery [3] - Short-term borrowings increased by 41.93% to 1.858 billion yuan, indicating rising debt pressure [11] - The current ratio stood at 0.73, highlighting liquidity concerns [1] Operational Insights - Accounts receivable decreased by 11.23% to 59.13 million yuan, while inventory surged by 141.07% due to increased raw material and finished goods requirements [4][7] - The company experienced a 21.73% decline in operating income, attributed to decreased production and sales [19] - Research and development expenses fell by 17.71%, indicating reduced investment in innovation [23] Cash Flow and Investment Activities - Net cash flow from operating activities plummeted by 447.27%, primarily due to reduced income from sales [24] - Cash flow from investment activities decreased significantly by 1168.73%, driven by increased investment in fundraising projects [25] - Cash flow from financing activities rose by 35.8%, reflecting an increase in borrowings [26] Historical Performance Context - The company's historical financial performance has been weak, with a median Return on Invested Capital (ROIC) of 2.56% over the past decade, and 11 years of losses since its listing [27] - The business model relies heavily on R&D and capital expenditures, necessitating careful scrutiny of the viability of these investments [27]